Mar 31, 2024 at 7:16 PM#6
Saving this for reference. Top-tier content.
47 11jim_asheville, matt_MKE, Dr.ReproEndo and 44 others
Reply Quote Save Share Report
Mar 31, 2024 at 7:33 PM#7
Slightly tangential to Has anyone dealt with is but ZaraB_AL reminded me — what is the latest on the oral formulations?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
44 8dave_SLC, FDA_TrackerJim, ricardo_MIA and 41 others
Reply Quote Save Share Report
Mar 31, 2024 at 7:50 PM#8
+1 to ZaraB_AL. Especially the point about "A few questions about your Has anyone de..." — I have seen the same in my own experience with Has anyone dealt with is.
Last edited: Mar 31, 2024 at 10:50 PM
23 5Admin, Dr.Martinez, mike_mod and 20 others
Reply Quote Save Share Report
PeptideMeter — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsMar 31, 2024 at 8:07 PM#9
newstart_MO — that is really helpful context on Has anyone dealt with is. Follow-up question: how long did you wait before increasing your dose?
I am in a similar situation (week 4) and trying to set realistic expectations.
19 3DanielChem_CHI, marco_milano, pam_columbus and 16 others
Reply Quote Save Share Report
Mar 31, 2024 at 8:24 PM#10
To answer VanRx_Mike's question specifically:
From a clinical standpoint, Has anyone dealt with is is a reasonable concern that deserves a thorough answer.
The short answer: the evidence supports this approach for most patients.
The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.
17 24rachel_ABQ, traveltech_sara, AttorneyGrant and 14 others
Reply Quote Save Share Report